Finally, understanding how the effects of HDAC6 on other basic cellular mechanisms may interfere with the vulnerability to α-Syn will be crucial in the future search for strategies to target HDAC6 for disease modification in α-Synucleinopathies. The gene discussed is HDAC6; the disease is synucleinopathy.